用于靶向金属蛋白酶的螯合剂片段文库。
Chelator fragment libraries for targeting metalloproteinases.
机构信息
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
出版信息
ChemMedChem. 2010 Feb 1;5(2):195-9. doi: 10.1002/cmdc.200900516.
Abstract
A chelator fragment library based on a variety of metal binding groups was screened against a metalloproteinase. Lead hits were identified and an expanded library of select compounds was synthesized, resulting in numerous high-affinity hits against several metalloprotein targets. The findings clearly demonstrate that chelators can be used to generate libraries suitable for fragment-based lead design (FBLD) directed at important metalloproteins.
摘要
基于多种金属结合基团的螯合剂片段库针对金属蛋白酶进行了筛选。鉴定出先导化合物，并合成了选择化合物的扩展文库，得到了针对几种金属蛋白酶靶标的许多高亲和力化合物。研究结果清楚地表明，螯合剂可用于生成适用于基于片段的先导设计（FBLD）的文库，以针对重要的金属蛋白酶。
相似文献
1
Chelator fragment libraries for targeting metalloproteinases.用于靶向金属蛋白酶的螯合剂片段文库。
ChemMedChem. 2010 Feb 1;5(2):195-9. doi: 10.1002/cmdc.200900516.
2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.基于片段的方法鉴定金属蛋白酶抑制剂的螯合剂。
J Med Chem. 2011 Jan 27;54(2):591-602. doi: 10.1021/jm101266s. Epub 2010 Dec 28.
3
A new role for old ligands: discerning chelators for zinc metalloproteinases.旧配体的新角色：锌金属蛋白酶的识别螯合剂
J Am Chem Soc. 2006 Mar 15;128(10):3156-7. doi: 10.1021/ja057957s.
4
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.用小分子抑制剂特异性靶向金属锌蛋白酶家族成员：应对多方面挑战的进展
Bioorg Med Chem. 2008 Oct 1;16(19):8781-94. doi: 10.1016/j.bmc.2008.08.058. Epub 2008 Aug 29.
5
In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups.含锌螯合基团的小分子基质金属蛋白酶抑制剂的原位“点击”组装
Org Lett. 2008 Dec 18;10(24):5529-31. doi: 10.1021/ol802286g.
6
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.基于结构的强效和选择性基质金属蛋白酶13抑制剂的设计与合成
J Med Chem. 2017 Jul 13;60(13):5816-5825. doi: 10.1021/acs.jmedchem.7b00514. Epub 2017 Jun 27.
7
Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.嘧啶-2,4,6-三酮：一类新型有效的选择性基质金属蛋白酶抑制剂。
Biol Chem. 2001 Aug;382(8):1277-85. doi: 10.1515/BC.2001.159.
8
From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases.从传感器到消音器：喹啉和苯并咪唑磺酰胺作为锌蛋白酶抑制剂。
J Am Chem Soc. 2010 Jun 23;132(24):8232-3. doi: 10.1021/ja101088j.
9
Inhibition of botulinum neurotoxin BoNT/A.肉毒杆菌神经毒素BoNT/A的抑制作用
Curr Top Med Chem. 2014;14(18):2043. doi: 10.2174/1568026614666141022095612.
10
Investigating chelating sulfonamides and their use in metalloproteinase inhibitors.研究金属蛋白酶抑制剂中的螯合磺胺及其应用。
Dalton Trans. 2012 Jun 7;41(21):6507-15. doi: 10.1039/c2dt12373h. Epub 2012 Mar 12.
引用本文的文献
1
Probing the metalloproteome: an 8-mercaptoquinoline motif enriches minichromosome maintenance complex components as significant metalloprotein targets in live cells.探索金属蛋白质组：一种8-巯基喹啉基序可富集微小染色体维持复合体成分，作为活细胞中重要的金属蛋白靶点。
RSC Chem Biol. 2024 Jun 25;5(8):776-786. doi: 10.1039/d4cb00053f. eCollection 2024 Jul 31.
2
ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.ChemFH：一种用于筛选化学生物学和药物发现中常见假阳性的综合工具。
Nucleic Acids Res. 2024 Jul 5;52(W1):W439-W449. doi: 10.1093/nar/gkae424.
3
MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery.MolProphet：一个用于药物发现早期阶段的一站式、通用且基于人工智能的平台。
J Chem Inf Model. 2024 Apr 22;64(8):2941-2947. doi: 10.1021/acs.jcim.3c01979. Epub 2024 Apr 2.
4
Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors.基于特性表征的新型金属酶抑制剂的发现：用于 HDAC1 抑制剂的策略和应用。
Molecules. 2024 Feb 29;29(5):1096. doi: 10.3390/molecules29051096.
5
"DompeKeys": a set of novel substructure-based descriptors for efficient chemical space mapping, development and structural interpretation of machine learning models, and indexing of large databases.“多姆佩键”：一组基于新颖子结构的描述符，用于高效的化学空间映射、机器学习模型的开发与结构解释以及大型数据库的索引编制。
J Cheminform. 2024 Feb 23;16(1):21. doi: 10.1186/s13321-024-00813-4.
6
Anticancer Tungstenocenes with a Diverse Set of (-), (,-) and (,-) Chelates-A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models.具有多种（-）、（，-）和（，-）螯合物的抗癌钨茂——通过3D球体模型改进评估的详细生物学研究
Pharmaceutics. 2023 Jul 3;15(7):1875. doi: 10.3390/pharmaceutics15071875.
7
Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches.4-羟基异亮氨酸的计算药理学与计算化学：物理化学、药代动力学及基于密度泛函理论的方法
Front Chem. 2023 Apr 13;11:1145974. doi: 10.3389/fchem.2023.1145974. eCollection 2023.
8
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology.E3 连接酶：遇见它们的“命中注定”——基于片段的方法发现新的 E3 配体并揭示 E3 生物学。
J Med Chem. 2023 Mar 9;66(5):3173-3194. doi: 10.1021/acs.jmedchem.2c01882. Epub 2023 Feb 23.
9
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.药物研发中的羟基吡喃酮衍生物：从螯合疗法到金属酶抑制剂的合理设计
RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19.
10
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set.阿斯利康的片段筛选：开发下一代生物物理片段集。
RSC Med Chem. 2022 Jul 4;13(9):1052-1057. doi: 10.1039/d2md00154c. eCollection 2022 Sep 21.
本文引用的文献
1
Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum.恶性疟原虫I类组蛋白去乙酰化酶小分子抑制剂的鉴定与表征
J Med Chem. 2009 Apr 23;52(8):2185-7. doi: 10.1021/jm801654y.
2
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.硫代酰胺羟基吡咯硫酮在对抗炭疽致死因子的效力上超过酰胺羟基吡咯硫酮。
J Med Chem. 2009 Feb 26;52(4):1063-74. doi: 10.1021/jm8013212.
3
Recent developments in fragment-based drug discovery.基于片段的药物发现的最新进展。
J Med Chem. 2008 Jul 10;51(13):3661-80. doi: 10.1021/jm8000373. Epub 2008 May 6.
4
Zinc-binding groups modulate selective inhibition of MMPs.锌结合基团调节基质金属蛋白酶的选择性抑制。
ChemMedChem. 2008 May;3(5):812-20. doi: 10.1002/cmdc.200700290.
5
A high-throughput screening approach to anthrax lethal factor inhibition.一种用于炭疽致死因子抑制的高通量筛选方法。
Bioorg Chem. 2007 Aug;35(4):306-12. doi: 10.1016/j.bioorg.2006.12.005. Epub 2007 Feb 22.
6
The design of inhibitors for medicinally relevant metalloproteins.用于医学相关金属蛋白的抑制剂设计。
ChemMedChem. 2007 Feb;2(2):152-71. doi: 10.1002/cmdc.200600204.
7
Fragment-based drug design: how big is too big?基于片段的药物设计：多大才算太大？
J Med Chem. 2006 Nov 30;49(24):6972-6. doi: 10.1021/jm060511h.
8
A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.针对金属蛋白酶家族的新型异羟肟酸文库：设计、平行合成与筛选
Bioorg Med Chem. 2007 Jan 1;15(1):63-76. doi: 10.1016/j.bmc.2006.10.010. Epub 2006 Oct 12.
9
Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.通过高通量筛选鉴定出的新型炭疽致死因子小分子抑制剂。
J Med Chem. 2006 Aug 24;49(17):5232-44. doi: 10.1021/jm0605132.
10
Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor.基于硫代吡喃酮的炭疽致死因子抑制剂的评估及结合模式预测
ChemMedChem. 2006 Jul;1(7):694-7. doi: 10.1002/cmdc.200600102.
Zotero 插件